Sunrest Lifescience Ltd (SUNREST) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sunrest Lifescience Ltd on NSE and BSE, with an AI summary of each filing.
SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business.
Intimation · 14 Nov 2026, 5:30 am
Sunrest Lifescience Schedules Board Meeting for H1 FY27 Results on 14th Nov'26 Sunrest Lifescience Limited has notified the stock exchange that its Board of Directors is scheduled to meet on 14th Nov'26. The board will consider, evaluate, and approve the company's half-yearly unaudited financial results for the period ended Sep'26, alongside other general business matters.
To consider and approve Unaudited Standalone and Consolidated financial results for the Half Year ended September 30, 2026 and other business matters
Intimation · 14 Nov 2026, 5:30 am
Sunrest Lifescience Schedules Board Meeting on 14th Nov'26 for Half-Yearly Results Sunrest Lifescience Limited has scheduled a meeting of its Board of Directors on Saturday, 14th Nov'26, at its registered office in Ahmedabad. The Board will consider and approve the standalone and consolidated unaudited financial results of the company for the quarter and half-year ended 30th Sep'26, alongside taking on record the Limited Review Report issued by the statutory auditor.
Sunrest Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter ended on 30th September, 2026
Others (Uncategorized) · 20 Oct 2026, 1:41 am
Sunrest Lifescience Confirms Corporate Governance Exemption for Q2 FY27 Sunrest Lifescience Limited confirmed the non-applicability of Regulation 27(2) corporate governance reporting under SEBI LODR Regulations for the quarter ended 30th Sep'26. The company qualifies for exemption under Regulation 15 as an NSE Emerge SME-listed entity. Additionally, practicing company secretary certification confirms that paid-up equity share capital remained at ₹4.29 crore across FY24–FY26 (below the ₹10.00 crore threshold) and net worth stood at ₹19.27 crore in FY26 (below the ₹25.00 crore limit), exempting it from mandatory filings.
SDD Compliance Certificate for the Quarter ended on 30th September, 2026
Others (Uncategorized) · 09 Oct 2026, 11:21 pm
Sunrest Lifescience Submits SDD Compliance Certificate for Quarter Ended 30th Sep'26 Sunrest Lifescience Limited has submitted its Structured Digital Database (SDD) Compliance Certificate for the quarter ended 30th Sep'26 to the National Stock Exchange of India, in accordance with Regulations 3(5) and 3(6) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Managing Director Nikhilkumar Yashvntlal Thakkar certified that the internal non-tamperable SDD system is fully operational with access controls, audit trail maintenance, 8-year record retention capability, and complete capture of all unpublished price-sensitive information (UPSI). No compliance breaches were observed during the quarter.
Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026 in relation to Dissolving the Right Issue due to non receipt of minimum subscription and other other matters
Outcome · 11 Sept 2026, 10:54 pm
Sunrest Lifescience Cancels Rights Issue Due to Inadequate Minimum Subscription Sunrest Lifescience's Board of Directors decided on 11th Sep'26 to dissolve its rights issue and unblock applicant funds. The issue, open from 18th Aug'26 to 2nd Sep'26 and extended to 11th Sep'26, failed to achieve the mandatory minimum subscription required under issue terms and Regulation 86 of SEBI ICDR Regulations, 2018.
Sunrest Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 07, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 07 Sept 2026, 10:18 pm
Sunrest Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 07, 2026
Annual General Meeting · 07 Sept 2026, 8:06 pm
Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on September 02, 2026, has decided to extend the issue of equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share.
Outcome · 02 Sept 2026, 10:33 pm
Sunrest Lifescience Extends 1:1 Rights Issue Closing Date to 11th Sep'26 Sunrest Lifescience's Board of Directors approved a nine-day extension for its ongoing 1:1 rights issue, priced at Rs. 35 per share. Originally scheduled to close on 2nd Sep'26, the subscription period will now conclude on 11th Sep'26. The decision, finalized during the board meeting on 2nd Sep'26, aims to provide shareholders additional time to exercise their rights.
Sunrest Lifescience Limited has informed the Exchange regarding 'General Operational Update'.
Others (Uncategorized) · 20 Aug 2026, 6:32 pm
Sunrest Lifescience Subsidiary Provides Order Execution Update Sunrest Lifescience's subsidiary, Hetvi Lifesciences Private Limited, provided an operational update on 20 Aug'26. The subsidiary is executing an order from Gujarat Medical Services Corporation Limited with a total value of approximately ₹9.22 Crore. As of the announcement date, work valued at ₹80.76 Lakhs has been executed and delivered. The company stated that execution is progressing as per planned timelines.
Sunrest Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 07, 2026
Annual General Meeting · 14 Aug 2026, 12:42 am
Sunrest Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 07, 2026
Annual General Meeting · 13 Aug 2026, 11:44 pm
Sunrest Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 07, 2026
Annual General Meeting · 13 Aug 2026, 11:39 pm
Outcome of Board Meeting held on 12th August, 2026
Outcome · 12 Aug 2026, 6:54 pm
Sunrest Lifescience Board Approves FY26 Annual Report and AGM Details Sunrest Lifescience's board, in its meeting on 12th Aug'26, approved the Annual Report for FY ended 31st Mar'26. The 9th Annual General Meeting (AGM) will be held on 07th Sep'26 at 12:30 P.M. via video conference. The cut-off date for e-voting eligibility is set for 28th Aug'26, with the e-voting period running from 04th Sep'26 to 06th Sep'26. The board also approved the re-appointment of directors Amitbhai Thakkar and Nikhilkumar Thakkar, and material related party transactions for FY27.
Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on August 07, 2026, has decided to issue equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share.
Rights Issue · 07 Aug 2026, 5:07 pm
SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2026 to consider Other business.
Intimation · 06 Aug 2026, 10:24 pm
Sunrest Lifescience Board to Meet on 12th Aug'26 Sunrest Lifescience has announced its Board of Directors will meet on 12 Aug'26. The agenda for the meeting is to consider other unspecified business matters. Investors should monitor for further disclosures regarding the specific items to be discussed.
To consider other business matters
Intimation · 06 Aug 2026, 10:23 pm
Sunrest Lifescience Board Meeting Scheduled for 12th Aug'26 to Approve FY26 Results Sunrest Lifescience has scheduled a Board of Directors meeting on 12th Aug'26 to consider several key agenda items. The board will approve the Annual Report and Directors' Report for the financial year ended 31st Mar'26. Additionally, the meeting will decide on the re-appointment of directors Mr. Amitbhai Thakkar and Mr. Nikhilkumar Thakkar. The board will also finalize the date for the 9th Annual General Meeting and approve material related party transactions for the financial year 2026-2027.
Sunrest Lifescience Limited has informed the Exchange that Record date for the purpose of Rights is 10-Aug-2026.
Others · 04 Aug 2026, 6:43 pm
Sunrest Lifescience Sets Record Date for 1:1 Rights Issue Sunrest Lifescience Limited has fixed 10th Aug'26 as the record date to determine shareholder eligibility for its upcoming Rights Issue. The company will issue one new equity share for every one fully paid-up equity share held by eligible shareholders on the record date. Each new share will have a face value of Rs.10. This action is pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015.
Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on August 04, 2026, has decided to issue equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share.
Rights Issue · 04 Aug 2026, 6:42 pm
Sunrest Lifescience Announces 1:1 Rights Issue at Rs. 35 per Share Sunrest Lifescience has approved a 1:1 rights issue, offering one new share for every one share held. The company will issue up to 4,291,200 equity shares at an issue price of Rs. 35 per share, including a premium of Rs. 25. The record date to determine eligibility is set for 10th Aug'26. The issue will open on 18th Aug'26 and close on 02nd Sep'26. Upon full subscription, the outstanding equity shares will increase from 4,291,200 to 8,582,400.
Sunrest Lifescience Limited has informed the Exchange about Board Meeting to be held on 04-Aug-2026 to consider and approve Fund raising/Other business.
Intimation · 03 Aug 2026, 7:05 pm
Sunrest Lifescience Board to Consider Fundraising on Aug 4th Sunrest Lifescience has announced a board meeting scheduled for 04-Aug'26. The primary agenda item is to consider and approve a proposal for fundraising. The board will also discuss other unspecified business matters. The outcome of this meeting could be material, as any potential equity issuance or debt raising may impact the company's capital structure and shareholding pattern.
SUNREST : 04-Aug-2026 : The Company has informed the Exchange that a Board meeting to be held on August 03, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 04, 2026, To consider Fund Raising and other business matters
Intimation · 03 Aug 2026, 7:01 pm
Sunrest Lifescience Postpones Board Meeting on Rights Issue Sunrest Lifescience has postponed its board meeting from 03rd Aug'26 to 04th Aug'26 due to non-receipt of in-principle approval from the NSE. The meeting is scheduled to determine the terms of its upcoming Rights Issue, including the issue price, entitlement ratio, and record date. This adjournment delays the finalization of key details for the proposed fundraising. The intimation complies with SEBI's Regulation 29.
Sunrest Lifescience Limited has informed the Exchange about Board Meeting to be held on 03-Aug-2026 to consider and approve Fund raising/Other business.
Intimation · 30 Jul 2026, 9:06 pm
Sunrest Lifescience Board to Consider Fundraising Sunrest Lifescience's Board of Directors will meet on 3rd Aug '26 to consider and approve a proposal for fundraising. The meeting's agenda also includes other unspecified business matters. Equity investors should monitor the outcome for potential dilution or strategic capital allocation plans.
SUNREST : 03-Aug-2026 : The Company has informed the Exchange that a Board meeting to be held on July 30, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 03, 2026, To consider Fund Raising and other business matters
Intimation · 30 Jul 2026, 9:01 pm
Sunrest Lifescience Board Meeting on Rights Issue Postponed Sunrest Lifescience has postponed its board meeting, originally scheduled for 30th Jul'26, to 03rd Aug'26. The delay is due to the non-receipt of in-principle approval from the National Stock Exchange. The meeting's agenda is to determine key terms for its upcoming Rights Issue, including the issue price, entitlement ratio, and record date. The outcome will be a key factor for existing shareholders and potential capital structure changes.
SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 30-Jul-2026 to consider and approve Fund raising/Other business.
Intimation · 24 Jul 2026, 6:48 pm
Sunrest Lifescience Board to Consider Fundraising on 30-Jul'26 Sunrest Lifescience has announced a board meeting scheduled for 30-Jul'26. The primary agenda item is to consider and approve proposals for fundraising. Other business matters will also be discussed. The potential for capital infusion through this fundraising initiative is a key development for the company and its equity valuation, pending the board's decision on the method and scale.
SUNREST : 30-Jul-2026 : The Company has informed the Exchange that a Board meeting to be held on July 24, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 30, 2026, To consider Fund Raising and other business matters
Intimation · 24 Jul 2026, 6:43 pm
Sunrest Lifescience Board Meeting on Rights Issue Postponed Sunrest Lifescience has postponed its board meeting, originally scheduled for 24th Jul'26, to 30th Jul'26. The delay is due to the non-receipt of an in-principle approval from the National Stock Exchange. The agenda remains to consider and approve the terms of its upcoming Rights Issue, including the issue price, entitlement ratio, and record date.
SUNREST : 24-Jul-2026 : The Company has informed the Exchange that a Board meeting to be held on July 17, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 24, 2026, To consider Fund Raising and other business matters
Intimation · 17 Jul 2026, 7:05 pm
Sunrest Lifescience Board Meeting on Rights Issue Postponed Sunrest Lifescience has postponed its board meeting, originally set for 17th Jul'26, to 24th Jul'26. The delay is due to the non-receipt of in-principle approval from the National Stock Exchange. The rescheduled meeting will focus on determining the terms of its upcoming Rights Issue, including the issue price, entitlement ratio, and record date.